Gyre Therapeutics Inc GYRE
News
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
Gyre Wins China Approval for Tablet to Treat Thrombocytopenia